Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma
- PMID: 14579085
- DOI: 10.1007/s00259-003-1297-8
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma
Abstract
Surgical resection is the only curative treatment strategy for intrahepatic cholangiocarcinoma (CC). Therefore, accurate staging is essential for appropriate management of patients with CC. We assessed the usefulness of 2-[(18)F]fluoro-2-deoxy- d-glucose (FDG) positron emission tomography (PET) in the staging of CC. We undertook a retrospective review of FDG PET images in 21 patients (10 female, 11 male; mean age 57 years) diagnosed with CC. Ten patients had hilar CC and 11, peripheral CC. Patients underwent abdominal magnetic resonance imaging (MRI) ( n=20) and computed tomography (CT) ( n=12) for the evaluation of primary tumours, and chest radiography and whole-body bone scintigraphy for work-up of distant metastases. For semi-quantitative analysis, the maximum voxel standardised uptake value (SUV(max)) was obtained from the primary tumour. All peripheral CCs showed intensely increased FDG uptake, and some demonstrated ring-shaped uptake corresponding to peripheral rim enhancement on CT and/or MRI. In nine of the ten patients, hilar CCs demonstrated increased FDG uptake of a focal nodular or linear branching appearance. The remaining case was false negative on FDG PET. One patient with a false negative result on MRI demonstrated increased uptake on FDG PET. Among the ten hilar CCs, FDG uptake was intense in only two patients and was slightly higher than that of the hepatic parenchyma in the remaining patients. For the detection of lymph node metastasis, FDG PET and CT/MRI were concordant in 16 patients, and discordant in five (FDG PET was positive in three, and CT and MRI in two). FDG PET identified unsuspected distant metastases in four of the 21 patients; all of these patients had peripheral CC. FDG PET is useful in detecting the primary lesion in both hilar and peripheral CC and is of value in discovering unsuspected distant metastases in patients with peripheral CC. FDG PET could be useful in cases of suspected hilar CC with non-confirmatory biopsy and radiological findings.
Similar articles
-
Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.J Gastroenterol Hepatol. 2008 May;23(5):759-65. doi: 10.1111/j.1440-1746.2007.05173.x. Epub 2007 Oct 10. J Gastroenterol Hepatol. 2008. PMID: 17931372
-
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.Hepatology. 2001 May;33(5):1029-35. doi: 10.1053/jhep.2001.23912. Hepatology. 2001. PMID: 11343227
-
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.Am J Gastroenterol. 2008 May;103(5):1145-51. doi: 10.1111/j.1572-0241.2007.01710.x. Epub 2008 Jan 2. Am J Gastroenterol. 2008. PMID: 18177454
-
The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.Surg Oncol. 2011 Mar;20(1):e10-7. doi: 10.1016/j.suronc.2009.08.003. Epub 2009 Oct 4. Surg Oncol. 2011. PMID: 19804967 Review.
-
[18F-FDG PET/CT in staging and restaging cholangiocarcinoma].Recenti Prog Med. 2013 Jul-Aug;104(7-8):328-35. doi: 10.1701/1315.14570. Recenti Prog Med. 2013. PMID: 24042402 Review. Italian.
Cited by
-
Intrahepatic cholangiocarcinoma: expert consensus statement.HPB (Oxford). 2015 Aug;17(8):669-80. doi: 10.1111/hpb.12441. HPB (Oxford). 2015. PMID: 26172134 Free PMC article.
-
The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.Ann Surg Oncol. 2021 May;28(5):2660-2674. doi: 10.1245/s10434-021-09671-y. Epub 2021 Mar 1. Ann Surg Oncol. 2021. PMID: 33646431
-
Differentiation between Malignant and Benign Solitary Lesions in the Liver with (18)FDG PET/CT: Accuracy of Age-related Diagnostic Standard.J Cancer. 2015 Jan 1;6(1):40-7. doi: 10.7150/jca.10422. eCollection 2015. J Cancer. 2015. PMID: 25553087 Free PMC article.
-
Diagnosis of Cholangiocarcinoma.Diagnostics (Basel). 2023 Jan 8;13(2):233. doi: 10.3390/diagnostics13020233. Diagnostics (Basel). 2023. PMID: 36673043 Free PMC article. Review.
-
Diagnosis of cholangiocarcinoma.HPB (Oxford). 2008;10(2):87-93. doi: 10.1080/13651820801992716. HPB (Oxford). 2008. PMID: 18773062 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical